札幌医科大学附属病院 病理診断科・病理部
 
研究業績

2020年2019年2018年2017年2016年2015年
2014年2013年2012年2011年2010年2009年
2008年2007年2006年 | 2005年 |

2005年度研究業績
1. Kinoshita T, Fukutomi T, Iwamoto E, Takasugi M, Akashi-Tanaka S, Hasegawa T. Intracystic papillary carcinoma of the breast in a male patient diagnosed by core needle biopsy: a case report. Breast 14: 322-324, 2005.
2. Ojima H, Hasegawa T, Matsuno Y, Sakamoto M. Extramedullary myeloid tumor (EMMT) of the gallbladder. J Clin Pathol 58: 211-213, 2005.
3. KounoT, Watanabe T, Umeda T, Beppu Y, Kojima R, Sungwon K, Kobayashi Y, Tobinai K, Hasegawa T, Matsuno Y. CD56-positive small round cell tumor: osseous plasmacytoma manifested in osteolytic tumors of the iliac bone and femora. Jpn J Clin Oncol 35: 90-93, 2005.
4. Tateishi U, Hasegawa T, Onaya H, Satake M, Arai Y, Moriyama N. Myxoinflammatory fibroblastic sarcoma: MR appearance and pathologic correlation. Am J Roentgenol 184: 1749-1753, 2005.
5. Sato O, Wada T, Kawai A, Yamaguchi U, Makimoto A, Kokai Y, Yamashita T, Chuman H, Beppu Y, Tani Y, Hasegawa T. Expression of epidermal growth factor receptor, HER2/neu, and CD117/c-kit in adult soft tissue sarcomas: a clinicopathological study of 281 cases. Cancer 103: 1881-1890, 2005.
6. Miyamoto K, Fukutomi T, Akashi-Tanaka S, Hasegawa T, Asahara T, Takashi Sugimura, Toshikazu Ushijima. Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer 116: 407-414, 2005.
7. Kawai A, Umeda T, Wada T, Ihara K, Isu K, Abe S, Ishii T, Sugiura H, Araki N, Ozaki T, Yabe H, Hasegawa T, Tsugane S, Beppu Y. Alternating sequential chemotherapy with high-dose ifosfamide and doxorubicin/cyclophosphamide for adult non-small round cell soft tissue sarcomas. J Orthop Sci 10: 258-263, 2005.
8. Tsuda H, Tani Y, Weisenberger J, Kitada S, Hasegawa T, Murata T, Tamai S, Hirohashi S, Matsubara O, Natori T. Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with ‘stem-cell-like’ features. Cancer Sci 96: 333-339, 2005.
9. Tsuda H, Mikami Y, Kaku T, Hasegawa T, Akiyama F, Ohishi Y, Sasajima Y, Kasamatsu T. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and ‘adenoma malignum’ based on common histopathological criteria. Pathol Int 55: 412-418, 2005.
10. Endo M, Hasegawa T, Tashiro T, Yamaguchi U, Morimoto Y, Nakatani F, Shimoda T. Bizarre parosteal osteochondromatous proliferation with a t(1;17) translocation. Virchows Arch 447: 99-102, 2005.
11. Tateishi U, Hasegawa T, Yamamoto S, Yamaguchi U, Yokoyama R, Kawamoto H, Satake M, Arai Y. Incidence of multiple primary malignancies in a cohort of adult patients with soft tissue sarcoma. Jpn J Clin Oncol 35: 444-452, 2005.
12. Tashiro T, Hasegawa T, Omatsu M, Sekine S, Shimoda T, Katai H. Gastrointestinal stromal tumor of the stomach showing lymph node metastases. Histopathology 47: 438-439, 2005.
13. Yamaguchi U, Hasegawa T, Morimoto Y, Tateishi U, Endo M, Nakatani F, Kawai A, Chuman H, Beppu Y, Endo M, Kurotaki H, Furuta K. A practical approach to clinical diagnosis of Ewing’s sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement by applying new fluorescence in situ hybridization probes for EWSR1 on formalin-fixed paraffin-embedded tissue. J Clin Pathol 58: 1051-1056, 2005.
14. Endo K, Takahashi M, Matsui Y, Hasegawa T, Yasui N. Bone tumor of the distal femur in a 67-year-old woman. Clin Orthop Relat Res 440: 262-268, 2005.
15. Shien T, Tashiro T, Omatsu M, Masuda T, Furuta K, Sato N, Akashi-Tanaka S, Uehara M, Iwamoto E, Kinoshita T, Fukutomi T, Tsuda H, Hasegawa T. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high-grade ductal carcinomas with myoepithelial differentiation. J Clin Pathol 58: 1299-1304, 2005.
16. Yamaguchi J, Ojima H, Hiraoka N, Hasegawa T. Poorly differentiated hepatocellular carcinoma with unusual tubular structures. J Clin Pathol 58: 1342, 2005.
17. Kondo S, Yamaguchi U, Sakurai S, Ikezawa Y, Chuman H, Tateishi U, Furuta K, Hasegawa T. Cytogenetic confirmation of a gastrointestinal stromal tumor and Ewing sarcoma/primitive neuroectodermal tumor in a single patient. Jpn J Clin Oncol 35: 753-756, 2005.
18. Kusumi T,Nishikawa S, Tanaka M, Ogawa T, Jin H, Sato F, Toh S, Hasegawa T, Kijima H. Low-grade fibromyxoid sarcoma arising in the big toe. Pathol Int 55: 802-806, 2005.
19. Miyake M, Tateishi U, Maeda T, Arai Y, Kazuro S, Hasegawa T. Extranodal Rosai-Dorfman disease: a solitary lesion with soft tissue reaction. Radiat Med 23: 439-442, 2005.
20. Tateishi U, Yamaguchi U, Terauchi T, Maeda T, Moriyama N, Arai Y, Hasegawa T. Extraskeletal osteosarcoma: extensive tumor thrombus on fused PET-CT images. Ann Nucl Med 19: 729-732, 2005.
21. Miyake M, Tateishi U, Maeda T, Arai Y, Hasegawa T, Sugimura K. MR features of angiosarcoma in a patient with Maffucci syndrome. Radiat Med 23: 508-512, 2005.
22. Yamaguchi T, Shimizu K, Koguchi Y, Saotome K, Ueda Y. Low-grade central osteosarcoma of the rib. Skeletal Radiol 34: 490-493, 2005.
23. Yamaguchi T,Takimoto T,Yamashita t,Kitahara S,Omura M,Ueda Y. Fat-containing variant of solitary fibrous tumor (lipomatous hemangiopericytoma) arising on the surface of the kidney. Urology 65: 175-174, 2005.
24. Yamaguchi T, Watanabe-Ishiiwa H, Suzuki S, Igarashi Y, Ueda Y. Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors. Mod Pathol 18: 1005-1010, 2005.
25. Abe T, Murakami A, Inoue T, Ohde S, Yamaguchi T, Watanabe K. Solitary fibrous tumor arising in the sphenoethmoidal recess: a case report and review of the literature. Auris Nasus Larynx 32: 285-289, 2005.
26. Koguchi Y, Yamaguchi T, Yamato M, Osada D, Saotome K. Alveolar soft part sarcoma of bone. J Orthop Sci 10: 652-655, 2005.
27. Murakami H, Kawahara N, Tomita K, Yamaguchi T. Letter to the editor. Spine 30: 593-594, 2005.
28. Sasaki A, Hinck L, Watanabe K. RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins.J Recept Signal Transduct Res. 25: 181-198, 2005.
29. Kawaguchi S, Wada T, Ida K, Sato Y, Nagoya S, Tsukahara T, Kimura S, Sahara H, Ikeda H, Shimozawa K, Asanuma H, Torigoe T, Hiraga H, Ishii T, Tatezaki S, Sato N, Yamashita T. Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. J Transl Med 3: 1, 2005.
30. Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N. A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clin Cancer Res 11: 1474-1482, 2005.
31. Hariu H, Hirohashi Y, Torigoe T, Asanuma H, Hariu M, Tamura Y, Aketa K, Nabeta C, Nakanishi K, Kamiguchi K, Mano Y, Kitamura H, Kobayashi J, Tsukahara T, Shijubo N, Sato N. Aberrant expression and potency as a cancer immunotherapy target of IAP family, Livin/ML-IAP in lung cancer. Clin Cancer Res 11: 1000-1009, 2005.
32. Asanuma H, Torigoe T, Kamiguchi K, Ohmura T, Hirata K, Sato M, Sato N. Survivin expression is regulated by co-expression of HER2 and EGFR via PI3K-AKT signaling pathway in breast cancer cells. Cancer Res 65: 11018-11025, 2005.
33. Yamamoto M, Torigoe T, Kamiguchi K, Hirohashi Y, Nakanishi K, Nabeta C, Asanuma H, Tsuruma T, Sato T, Hata F, Ohmura T, Yamaguchi K, Kurotaki T, Hirata K and Sato N. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis. Cancer Res 65: 8706-8714, 2005.
34. Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol 36: 234-241, 2005.
35. Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A, Noguchi M, Nagai I, Hiratsuka H. Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 18: 1482-1489, 2005.
36. 長谷川匡. 軟部腫瘍の病理組織分類-含: 組織学的悪性度分類-. 越智隆弘, 菊地臣一編. NEW MOOK 整形外科 No. 18 骨・軟部腫瘍. 東京: 金原出版; pp22-35, 2005.
37. 長谷川匡. 病理組織診断, 免疫組織化学染色による鑑別診断. GIST研究会編. NCCN治療ガイドライン. 消化管間質腫瘍(GIST)の治療と患者の至適管理解説書. 東京: エルゼビア・ジャパン; pp16-21, 2005.
38. 尾松睦子, 長谷川匡. 細胞診. 福富隆志編. 乳癌診療ハンドブック. 東京: 中外医学社; pp79-84, 2005.
39. 田代敬, 長谷川匡. GISTの悪性度評価. 臨床消化器内科20: 1249-1257, 2005.
40. 長谷川匡. 軟部腫瘍の遺伝子異常と確定診断への応用. 医学のあゆみ 214: 966-967, 2005.
41. 村井香織, 東恭悟, 浅沼広子, 木村幸子, 池田健, 佐藤昌明. 副腎に発生した神経節芽腫(Ganglioneuroblastoma)の1例. 日臨細胞北海道会報. 14: 20-23, 2005.
42. 宮川康宏, 東恭悟, 植松正, 石田徹, 内田善一, 加藤 修、佐藤美幸, 高橋学, 田中浩樹, 中野成紀, 野崎正行, 水上恵子, 森谷 純, 中村厚志, 清水幹雄, 小林克己. 細胞診プレパラートサーベイ実施報告(第11回). 日臨細胞北海道会報. 14: 36-44, 2005.
43. 大内知之. 腺癌NOS. 日本唾液腺学会編; 唾液腺腫瘍アトラス.第1版, 東京: 金原出版; pp113-114, 2005.
44. 大内知之. 嚢胞腺癌. 日本唾液腺学会編; 唾液腺腫瘍アトラス. 第1版, 東京: 金原出版; pp115-117, 2005.
45. 大内知之. 粘液腺癌. 日本唾液腺学会編; 唾液腺腫瘍アトラス. 第1版, 東京: 金原出版; pp118-119, 2005.
46. 大内知之. 唾液腺導管癌. 日本唾液腺学会編; 唾液腺腫瘍アトラス. 第1版, 東京: 金原出版; pp120-124, 2005.
▲上に戻る
 
TOPご挨拶病理診断科・病理部についてメンバー紹介教育・研修のお知らせ研究内容研究業績リンクお問い合わせ
copyright(C)2006 Sapporo Medical University Hospital. All right reserved.
 
リンク お問い合わせ